Personal value of Alzheimer's disease biomarker testing
The personal utility outcomes of the IMPACT-AD BC study have now been peer-reviewed and published in one of the leading journals in the...
Personal value of Alzheimer's disease biomarker testing
Clinical value of Alzheimer's disease biomarker testing
A national leader in Alzheimer’s care
Understanding frontotemporal dementia
Perspectives on testing from persons with lived experience
Alzheimer Society webinar on biomarker testing
Who, what, where & when of Alzheimer's testing
First-in-Canada testing program for Alzheimer’s
Biomarker testing guides in multiple languages
Alzheimer's disease testing innovation
2020 Alzheimer Update
Dr. Stites talks to the New York Times about early diagnosis
Changing the future for people affected by dementia
Brain Canada & Health Canada fund the IMPACT-AD study!